Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer

NCT04954378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-07-08

No results posted yet for this study

Summary

Retrospectively analyzed radiomics features of pancreatic ductal adenocarcinoma to predict staging and prognosis

Conditions

Interventions

DIAGNOSTIC_TEST

radiomics

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Huishu Yuan · Peking University Third Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2020-12-30
Completion
2020-12-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04954378 on ClinicalTrials.gov